| Dr Stephen A Hamilton, MD | |
|
230 N Midwest Blvd, Midwest City, OK 73110-4321 | |
| (405) 737-8455 | |
| (405) 739-8707 |
| Full Name | Dr Stephen A Hamilton |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 230 N Midwest Blvd, Midwest City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043210370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 18028 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen A Hamilton, MD 230 N Midwest Blvd, Midwest City, OK 73110-4321 Ph: (405) 737-8455 | Dr Stephen A Hamilton, MD 230 N Midwest Blvd, Midwest City, OK 73110-4321 Ph: (405) 737-8455 |
News Archive
Boosting levels of two critical proteins that normally shut down during Huntington's disease, researchers at the University of Wisconsin-Madison and the Cold Spring Harbor Laboratory have cured fruit flies of the genetic, neurodegenerative condition.
Studies have shown a high rate of depression among elderly homebound individuals, and few patients receive adequate treatment, if any. To address this issue, researchers at Rhode Island Hospital and other organizations have developed a telemedicine-based depression care protocol in home health care.
Noile-Immune Biotech Inc., ("Noile-Immune") and C4U Corporation, ("C4U") announced that they have entered into an agreement on joint research and commercialization of next-generation allogeneic gene-modified immune cell therapy combining C4U's CRISPR/Cas3 genome editing technology and Noile-Immune's PRIME (Proliferation inducing and migration enhancing) technology designed to improve proliferation and trafficking of immune cells into solid tumors.
The medication tetrabenazine cut down involuntary movement in patients with Huntington's disease on average by about 25 percent, with many patients experiencing a greater improvement, according to a study in the February 14 issue of the journal Neurology.
› Verified 5 days ago
Dr. Mohammed Naveed Ahmed, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8121 National Ave Ste 300, Midwest City, OK 73110 Phone: 405-610-3023 Fax: 405-733-0779 | |
Dr. Bereket Alemu, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9230 E Reno Ave, Suite B, Midwest City, OK 73130 Phone: 405-737-4900 Fax: 405-737-3606 | |
Vaqar Ahmad, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8121 National Ave, Suite 402, Midwest City, OK 73110 Phone: 405-736-6095 Fax: 405-736-6682 | |
Aneesh Venkat Pakala, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6951 Se 15th St, Midwest City, OK 73110 Phone: 405-233-0450 Fax: 405-233-0451 | |
Arif A Shakir, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 412 S Air Depot Blvd, Ste B, Midwest City, OK 73110 Phone: 405-737-2800 Fax: 405-737-2858 | |
Dr. Samson Mulu Ambaw, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9230 E. Reno Ave Suite B, Midwest City, OK 73130 Phone: 405-737-4900 Fax: 405-737-3606 |